Loading...
Back to narrative

Update shared on25 Sep 2025

Fair value Increased 2.05%
AnalystConsensusTarget's Fair Value
US$85.64
3.4% overvalued intrinsic discount
25 Sep
US$88.59
Loading
1Y
6.4%
7D
6.5%

Despite consensus revenue growth forecasts declining and forward P/E rising, indicating more expensive valuation relative to growth prospects, Sempra’s analyst price target has edged up from $83.92 to $85.64.


What's in the News


  • Sempra updated its 2025 GAAP EPS guidance to a range of $3.29 to $3.69, affirming a long-term compound annual EPS growth target of 7% to 9% through 2029.
  • Sempra subsequently updated its 2025 GAAP EPS guidance to a higher range of $4.05 to $4.45 and set 2026 EPS guidance at $4.80 to $5.30, while reaffirming the targeted 7% to 9% EPS CAGR through 2029.

Valuation Changes


Summary of Valuation Changes for Sempra

  • The Consensus Analyst Price Target has risen slightly from $83.92 to $85.64.
  • The Consensus Revenue Growth forecasts for Sempra has significantly fallen from 7.6% per annum to 6.8% per annum.
  • The Future P/E for Sempra has risen from 19.31x to 21.04x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.